US · Healthcare

Vanda Pharmaceuticals Inc (VNDA)

Biotechnology

Vanda Pharmaceuticals Inc (VNDA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for VNDA

P/E ratio

25.00

Vanda Pharmaceuticals Inc (VNDA) — FAQ

What is VNDA's P/E ratio?

The price-to-earnings (P/E) ratio for Vanda Pharmaceuticals Inc (VNDA) is 25.00 (data as of 2026-05-24).

Does Vanda Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Vanda Pharmaceuticals Inc (VNDA). Check the MyAverix Finance app for the latest dividend data.

What sector is Vanda Pharmaceuticals Inc in?

Vanda Pharmaceuticals Inc (VNDA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is VNDA listed on?

VNDA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)